510(k) Report

510(k) · Cleared

Cleared

BioCardia 8F Morph DNA Deflectable Guide Catheter

K192774510(k) SpecialCleared Jan 7, 202099-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biocardia · DQY Catheter, Percutaneous

Cleared on Jan 7, 2020 as substantially equivalent to K042553 (Biocardia, Inc., 2005) after a 99-day review. Its family tree reaches back 4 generations to 1994. 1 later device descends from it.

Decided
Jan 7, 2020
Review
99 days
Class
Class II
Product code
DQY
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K931794 (1994). 7 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 4 generations backK931794 Marinr Series EP Diagnostic CathetersMedtronic Cardiorhythm · 1994
  2. 3 generations backK974683 Naviport Deflectable Tip Guiding CatheterCardima, Inc. · 1999
  3. 2 generations backK012749 Biocardia Universal Deflectable Guide Catheter, Model 000664Biocardia, Inc. · 2002
  4. 1 generation backK042553 Biocardia Morph Universal Deflectable Guide CatheterBiocardia, Inc. · 2005
  5. This deviceK192774 BioCardia 8F Morph DNA Deflectable Guide CatheterBiocardia · 2020
  6. Descendant · cites it directly · 0 of its ownK242169 Morph DNA Steerable Introducer SheathBiocardia · 2024

Most influential descendants

Showing 1 of 1 · See all
  • K242169Morph DNA Steerable Introducer SheathBiocardia · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K931794Marinr Series EP Diagnostic CathetersMedtronic Cardiorhythm1994—
−3K974683Naviport Deflectable Tip Guiding CatheterCardima, Inc.1999—
−2K012749Biocardia Universal Deflectable Guide Catheter, Model 000664Biocardia, Inc.2002—
−1K042553Biocardia Morph Universal Deflectable Guide CatheterBiocardia, Inc.2005—
0 (this device)K192774BioCardia 8F Morph DNA Deflectable Guide CatheterBiocardia2020—
+1K242169Morph DNA Steerable Introducer SheathBiocardia2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199620
199710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
FIG. 1 — Lineage of K192774, 1994–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DQY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DQY device

  1. #1 K234115 APRO 55 Catheterscore 17.5 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K042553Biocardia Morph Universal Deflectable Guide Catheter
Summary page 4
…ation Name: Percutaneous Catheter Product Code: DQY Predicate Device: BioCardia Morph Universal Deflectable Guide Catheter K042553 Device Description: The BioCardia 8F Morph® DNA Deflectable Guide Catheter is a sterile, single use, bi-directional deflectable…
Biocardia, Inc.2005—

Also cleared against K042553: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K242169Morph DNA Steerable Introducer SheathBiocardia20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 4 companies; a new generation was cleared every 5.0 years on median.
  • None of the 7 ancestors has a recall.
  • Of its descendants, K242169 (Biocardia, 2024) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K042553.

How does its category compare?

All DQY devices

DQY Catheter, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · DQY

21in 2025

2007: 162008: 312009: 372010: 222011: 362012: 302013: 322014: 192015: 272016: 222017: 262018: 252019: 302020: 202021: 182022: 182023: 182024: 162025: 212026 (partial year): 11
2007high 37 (2009) · low 16 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DQY

115in 2025

2007: 85 days median2008: 66 days median2009: 73 days median2010: 74 days median2011: 71 days median2012: 87 days median2013: 92 days median2014: 127 days median2015: 118 days median2016: 117 days median2017: 113 days median2018: 106 days median2019: 111 days median2020: 120 days median2021: 81 days median2022: 74 days median2023: 114 days median2024: 87 days median2025: 115 days median2026 (partial year): 30 days median
2007high 127 (2014) · low 66 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DQY

1in 2025

2007: 62008: 122009: 172010: 322011: 62012: 22013: 36, 1 Class I2014: 32015: 32016: 22, 7 Class I2017: 82018: 22019: 12020: 22021: 22023: 172024: 12025: 1, 1 Class I2026 (partial year): 2, 1 Class I
2007high 36 (2013) · low 0 (2022)2026

Class I (10 since 2007) Class II/III not classified

Adverse event reports per year · DQY

3,056in 2025

2007: 3132008: 4962009: 8192010: 1,2932011: 1,2112012: 1,1912013: 1,3522014: 1,4972015: 2,3372016: 2,2522017: 2,4892018: 2,8552019: 2,9022020: 2,8892021: 3,0062022: 2,6432023: 3,0492024: 3,1902025: 3,056
2007high 3,190 (2024) · low 313 (2007)2025

MAUDE reports naming product code DQY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200716856313
2008316612496
2009377317819
20102274321,293
2011367161,211
2012308721,191
2013329236 (1)1,352
20141912731,497
20152711832,337
20162211722 (7)2,252
20172611382,489
20182510622,855
20193011112,902
20202012022,889
2021188123,006
2022187402,643
202318114173,049
2024168713,190
2025211151 (1)3,056
202611302 (1)—

What is it indicated for?

The biocardia morph universal deflectable guide catheter is intended to provide a pathway through which medical instruments, such as balloon dilatation catheters, guidewires, or other therapeutic devices may be introduced into the peripheral vasculature or chambers and coronary vasculature of the heart.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K192774: BioCardia 8F Morph DNA Deflectable Guide Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K192774

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026